Athira Pharma Inc (NAS:ATHA) Stock News, Headlines & Updates
Athira Pharma Inc Stock News from GuruFocus
- 1
Aug 01, 2024
Athira Pharma Reports Second Quarter 2024 Financial Results and Pipeline and Business Updates
Marketwired • 4:00pm
Jul 09, 2024
Athira Pharma Announces Last Patient Completed LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer's Disease
Marketwired • 6:00am
Jun 26, 2024
Director Kelly Romano Acquires 42,400 Shares of Athira Pharma Inc (ATHA)
GuruFocus Research • 1:46am
Jun 12, 2024
Athira to Host Webinar Highlighting Potential for Fosgonimeton to Protect and Preserve Neuronal Health in Mild-to-Moderate Alzheimer's Disease Patients
Marketwired • 6:00am
Jun 11, 2024
Athira Pharma Completes First Cohort in Phase 1 Clinical Trial of ATH-1105, an Oral, Small Molecule Drug Candidate for Amyotrophic Lateral Sclerosis (ALS)
Marketwired • 6:00am
May 29, 2024
Athira Pharma to Participate in Upcoming June Conferences
Marketwired • 6:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news